Global Pacemaker MarketGrowth 2020 Overview, Segments, Regional Analysis

31/mag/2020 16:08:07 Market Research Future Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Pacemaker Market Research Report: Information by Implantability (Implantable Pacemakers and External Pacemaker), Technology (Dual-Chamber Pacemakers, Single-Chamber Pacemakers and Biventricular/CRT Pacemakers), Type (MRI Compatible Pacemakers and Conventional Pacemakers), End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025

GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/1587

Global Pacemaker Market - Overview

A pacemaker is a small device that is used to regulate your heart rhythm. The global pacemaker market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Cardiac pacemaker are the artificial heart rhythm management devices which regularize the heartbeats by sending the electrical impulses to the heart. External pacemakers are the temporary pacing devices which are used during the cardiac surgical procedures to maintain the heartbeat rhythms. External pacemakers require a fully furbished clinical facility. On the other hand, implantable pacemakers are placed inside the skin on the left side of the chest of the patient. The normal life of an implantable pacemaker device is said to be 10 years. The average cost of the device is around $10000 in US. But due to the favourable reimbursement policies of the government, it becomes affordable for the people to undergo the implantation procedure leading to the growth of the market. Among the two types implantable and external, implantable cardiac pacemakers are the most preferred pacemakers by the physicians.

Market Research Future published a Half-Cooked Research Report on “Global Pacemaker Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

Global Pacemaker Market - Competitive Analysis

July, 2016- BIOTRONIK had received CE approval for its Edora pacemakers and cardiac resynchronization therapy pacemakers. Biotronik is one of the global leader in cardio- and endovascular medical technology, and is headquartered in Berlin, Germany, and represented in over 100 countries. Many patients have used company implants with improved quality, or have been treated with company’s coronary and peripheral vascular intervention products. However, the company was first to develop pacemaker in 1963, moreover the company has engineered many innovations, which includes Magmaris, the first clinically proven bioresorbable magnesium scaffold, Home Monitoring, Pulsar 18- the world's first 4 F compatible stent for treating long lesions, Orsiro, first hybrid drug-eluting stent; and the world's first implantable cardioverter defibrillators and heart failure therapy devices with ProMRI technology

Intended Audience

  • Cardiovascular disorders treatment centers
  • Contract research organizations (CROs)
  • Research and development (R&D) companies
  • Government research laboratories
  • Independent research laboratories
  • Government and independent regulatory authorities
  • Market research and consulting service providers
  • Medical research laboratories
  • Academic medical institutes and universities

Report Details @ https://www.marketresearchfuture.com/reports/pacemaker-market-1587

 

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

 

 
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl